New publication – Science Translational Medicine

“The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance” Dr Gilles Courtemanche, BIOASTER Antimicrobials Program Head is co-author of a scientific publication...

BIOASTER publishes a new article in Frontiers in Immunology .

BIOASTER in collaboration with Cochin Hospital and the REALISM project consortium (study of the pathophysiology of intensive care patients and on biomarkers), has just published the article entitled “Assessing the...

DxPX Conference support to the Virtual US event in July

BIOASTER is proud to support DxPx Conference Industry & Investor Conference, the unique international partnering conference with focus on #diagnostics, #PrecisionMedicine & research tools. During the virtual US event from July 27th – 31st, 2021, Xavier Morge,...

KALEIDO & BIOASTER: a successful completion

Kaleido Biosciences and BIOASTER are glad to announce the successful completion of a collaborative project that provided new insights into ways Kaleido’s Microbiome Metabolic Therapies (MMT™) modulate the integrity and function of...